Book contents
- Liver Disease in Children
- Liver Disease in Children
- Copyright page
- Contents
- Contributors
- Preface
- Section I Pathophysiology of Pediatric Liver Disease
- Section II Cholestatic Liver Disease
- Section III Hepatitis and Immune Disorders
- Section IV Metabolic Liver Disease
- Chapter 24 Laboratory Diagnosis of Inborn Errors of Liver Metabolism
- Chapter 25 α1-Antitrypsin Deficiency
- Chapter 26 Cystic Fibrosis Liver Disease in Children
- Chapter 27 Inborn Errors of Carbohydrate Metabolism
- Chapter 28 Copper Metabolism and Copper Storage Disorders in Children
- Chapter 29 Iron Storage Disorders in Children
- Chapter 30 Heme Biosynthesis and the Porphyrias in Children
- Chapter 31 Tyrosinemia in Children
- Chapter 32 Lysosomal Storage Disorders in Children
- Chapter 33 Disorders of Bile Acid Synthesis and Metabolism in Children
- Chapter 34 Inborn Errors of Fatty Acid Oxidation
- Chapter 35 Mitochondrial Hepatopathies
- Chapter 36 Non-Alcoholic Fatty Liver Disease in Children
- Chapter 37 Peroxisomal Disorders in Children
- Chapter 38 Urea Cycle Disorders in Children
- Section V Other Considerations and Issues in Pediatric Hepatology
- Index
- References
Chapter 28 - Copper Metabolism and Copper Storage Disorders in Children
from Section IV - Metabolic Liver Disease
Published online by Cambridge University Press: 19 January 2021
- Liver Disease in Children
- Liver Disease in Children
- Copyright page
- Contents
- Contributors
- Preface
- Section I Pathophysiology of Pediatric Liver Disease
- Section II Cholestatic Liver Disease
- Section III Hepatitis and Immune Disorders
- Section IV Metabolic Liver Disease
- Chapter 24 Laboratory Diagnosis of Inborn Errors of Liver Metabolism
- Chapter 25 α1-Antitrypsin Deficiency
- Chapter 26 Cystic Fibrosis Liver Disease in Children
- Chapter 27 Inborn Errors of Carbohydrate Metabolism
- Chapter 28 Copper Metabolism and Copper Storage Disorders in Children
- Chapter 29 Iron Storage Disorders in Children
- Chapter 30 Heme Biosynthesis and the Porphyrias in Children
- Chapter 31 Tyrosinemia in Children
- Chapter 32 Lysosomal Storage Disorders in Children
- Chapter 33 Disorders of Bile Acid Synthesis and Metabolism in Children
- Chapter 34 Inborn Errors of Fatty Acid Oxidation
- Chapter 35 Mitochondrial Hepatopathies
- Chapter 36 Non-Alcoholic Fatty Liver Disease in Children
- Chapter 37 Peroxisomal Disorders in Children
- Chapter 38 Urea Cycle Disorders in Children
- Section V Other Considerations and Issues in Pediatric Hepatology
- Index
- References
Summary
Excess copper in the liver is toxic in humans and other mammals, and may lead to acute or chronic hepatitis, steatohepatitis, acute liver failure, cirrhosis and death. Of the several human copper storage diseases that have been described, the molecular basis of only Wilson disease is understood with the discovery of the Wilson disease gene (ATP7B) in 1993. The therapeutic success using oral copper chelating agents and zinc therapy make Wilson disease one of the few treatable genetic metabolic liver diseases. In cases with a fulminant presentation or advanced disease at diagnosis, copper chelation is ineffective and liver transplantation may be lifesaving. Indian Childhood Cirrhosis (ICC) has been defined as a copper-storage disorder precipitated by increased copper intake which affects young children primarily of Indian descent, and which progresses to cirrhosis and death before age three to four years without treatment. Children from North America, Asia, Austria, Germany and other countries have been described with a similar condition, which has been termed idiopathic copper toxicosis (ICT). Several newer disorders of hepatic copper metabolism have been recently described.
- Type
- Chapter
- Information
- Liver Disease in Children , pp. 484 - 514Publisher: Cambridge University PressPrint publication year: 2021
References
References
Websites of Interest
GeneReviews – Wilson Disease: www.ncbi.nlm.nih.gov/books/NBK1512/ [last accessed June 21, 2020].
Wilson Disease Association: www.wilsonsdisease.org/ [last accessed June 21, 2020].
National Organization for Rare Disorders: https://rarediseases.org/rare-diseases/wilson-disease/ [last accessed June 21, 2020].
Genetics and Rare Disease Information Center: https://rarediseases.info.nih.gov/diseases/7893/disease [last accessed June 21, 2020].
- 3
- Cited by